COMPANY PROFILE

Transverse Medical

Explore full profile

Transverse Medical has developed the *POINT-GUARD™ the only solution for complete cerebral embolic protection

Denver, United StatesFounded 2011Health Tech & Medtech

Valuation $25–50M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Transverse Medical

Transverse Medical is a pioneering company in the medical device industry, focusing on developing innovative solutions to minimize the risk of stroke during cardiovascular procedures. The company's core product is a cerebral embolic protection device designed to provide maximum coverage and filtering of cerebral embolic debris particles, thereby reducing the risk of stroke. This device is currently limited to investigational use and is not yet approved for sale by any regulatory authority, including the FDA. Transverse Medical primarily serves healthcare providers and institutions involved in cardiovascular procedures. By reducing the risk of stroke, the company aims to decrease patient and healthcare costs, resulting in substantial cost savings for the healthcare system. The business model revolves around clinical investigations and eventual commercialization of their cerebral embolic protection device once regulatory approvals are obtained. Revenue generation is anticipated through the sale of these devices to hospitals and healthcare facilities, as well as potential partnerships and licensing agreements.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2011
Headquarters: Denver, United States
Employees: 15
Open positions: None listed
Dealroom signal: 36.2/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Surgery, Cardiology and cardiovascular, Neurology, Hard Tech, DT and LS, science-based, stroke
Technology: Deep Tech
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Apr 2025	$10M	$40M	Undisclosed	↗
EARLY VC✓Equity / VC	Aug 2023	$6.6M	$27M	Undisclosed	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Transverse Medical website traffic

Latest recorded traffic for Transverse Medical is 1.9K monthly website visits, up 143.6% over the last three months. Transverse Medical's team declined 21.1% over the past year.

Latest monthly visits1.9K 3-month web change+143.6% 1-year team growth-21.1%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SCStroke CareFocusing on the development and industrialization of new minimally invasive interventional technologies for stroke prevention and treatment	Huangpu, China	Operational	14	$24M	$40M
LMLairui MedicalDeveloper and manufacturer of neurointerventional medical devices designed to provide solutions for ischemic and hemorrhagic stroke	China	Operational
QMQ’Apel MedicalDesigning novel access device technology for neurovascular interventions and unmet clinical needs	Fremont, United States	Operational
NTNeuroVasc TechnologiesMaking a mechanical thrombectomy device in order to reduce the risk of death	Laguna Hills, United States	Operational
EMEmbolineDeveloped the only embolic protection device designed to provide complete protection of the brain and other critical organs by capturing and removing emboli produced during the procedure	Santa Cruz, United States	Operational
RORobocathInnovative solutions for the treatment of cardiovascular diseases	Rouen, France	Acquired
TMTrice MedicalFounded to fundamentally improve orthopedic diagnostics for the patient	Charlestown Township, United States	Operational
BTBendit TechnologiesDeveloping navigational microcatheters with 3D controlled steering that can be piloted in the body	Petah Tikva, Israel	Operational